Companies: 49,253 Total Market Cap: 132487166788946.79

Kolon Life Science

KOSDAQ-102940

Medicinal Chemicals and Botanical Products

Rank #18895

Market Cap 230.26 M

Volume 25,926

Price 18.39

Change (%) 0.78%

Country or region

South Korea

Kolon Life Science's latest marketcap:

230.26 M

As of 05/21/2025, Kolon Life Science's market capitalization has reached $230.26 M. According to our data, Kolon Life Science is the 18895th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.

Market Cap	230.26 M
Revenue (ttm)	116.84 M
Net Income (ttm)	-67,394,199.70
Shares Out	12.42 M
EPS (ttm)	-5.64
Forward PE	0.00
Ex-Dividend Date	n/a
Earnings Date	05/14/2025

Market Cap Chart

Data Updated: 05/21/2025

Kolon Life Science's yearly market capitalization.

Kolon Life Science has seen its market value drop from ₩331.41 B to ₩318.04 B since 2020, representing a total decrease of 4.03% and an annual compound decline rate (CAGR) of 0.93%.

Date	Market Cap	Change (%)
05/21/2025	₩318.04 B	5.87%
12/30/2024	₩285.74 B	-2.58%
12/28/2023	₩293.30 B	-6.2%
12/29/2022	₩312.70 B	-36.58%
12/30/2021	₩493.06 B	48.78%
12/30/2020	₩331.41 B

Company Profile

About Kolon Life Science Inc.

Kolon Life Science Inc. is a biotechnology company specializing in the development of innovative cell and gene therapy products. Headquartered in Seoul, South Korea, the company was founded in 2000 and has since been at the forefront of biopharmaceutical advancements.

Key Product Candidates

KLS-2031: Currently in Phase 1 clinical trials for the treatment of neuropathic pain.
KLS-3021: An oncolytic viral therapy in pre-clinical development.

Additional Services & Offerings

Supply of active pharmaceutical ingredients (APIs) and pharmaceutical intermediates.
Contract Development and Manufacturing Organization (CDMO) and Contract Manufacturing Organization (CMO) services.
Pyrithione antimicrobial solutions for personal care and industrial applications.

Corporate Background

Formerly known as Korea Tissuegene Asia, Ltd., the company rebranded to Kolon Life Science Inc. in January 2006.

Frequently Asked Questions

As of 05/21/2025, Kolon Life Science (including the parent company, if applicable) has an estimated market capitalization of $230.26 M USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.

Kolon Life Science global market capitalization ranking is approximately 18895 as of 05/21/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.

Stock Detail

Country or region	South Korea
Founded	2000
IPO Date	n/a
Employees	420
CEO	Sun Jin Kim
Sector
Industry	Medicinal Chemicals and Botanical Products
Address	One & Only Tower Seoul South Korea
Website	https://www.kolonls.co.kr